ABSTRACT
The vaccinia virus complement control protein (VCP) blocks classic and alternate complement pathways by binding to the third and fourth complement components and by blocking the formation of the C3-convertase as well as by accelerating the decay of the C3 and C4 convertase. The therapeutic potential of VCP has been extensively studied for brain injury, xenotransplantation, Alzheimer's disease, and spinal cord injury. We investigated the pharmacokinetic behavior of rVCP in mice. Dosage of rVCP was studied by injecting different concentrations of rVCP. A 25 mg/kg or greater dose injected intraperitoneally was found to be adequate to suppress complement for more than 8 hours.
Subject(s)
Graft Rejection/prevention & control , Transplantation, Heterologous/physiology , Viral Proteins/pharmacokinetics , Viral Proteins/therapeutic use , Animals , Mice , Recombinant Proteins/pharmacokinetics , Recombinant Proteins/therapeutic useABSTRACT
Vaccinia virus complement control protein (VCP) has been shown to possess the ability to inhibit both classical and alternative complement pathway activation. The newly found ability of this protein to bind to heparin has been shown in previous studies to result in uptake by mast cells, possibly promoting tissue persistence. It has also been shown to reduce chemotactic migration of leukocytes by blocking chemokine binding. In addition, this study shows that VCP-through its ability to bind to glycosaminoglycans (heparin-like molecules) on the surface of human endothelial cells-is able to block antibody binding to surface major histocompatibility complex class I molecules. Since heparin binding is critical for many functions of this protein, we have attempted to characterize the molecular basis for this interaction. Segments of this protein, generated by genetic engineering of the DNA encoding VCP into the Pichia pastoris expression system, were used to localize the regions with heparin binding activity. These regions were then analyzed to more specifically define their properties for binding. It was found that the number of putative binding sites (K/R-X-K/R), the overall positive charge, and the percentage of positively charged amino acids within the protein were responsible for this interaction.
Subject(s)
Conserved Sequence , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Heparin/metabolism , Poxviridae/immunology , Viral Proteins/chemistry , Viral Proteins/metabolism , Amino Acid Motifs , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Binding Sites , Complement Inactivator Proteins/chemistry , Complement Inactivator Proteins/genetics , Complement Inactivator Proteins/immunology , Complement Inactivator Proteins/metabolism , Endothelium, Vascular/cytology , Hemolysis , Histocompatibility Antigens Class I/immunology , Humans , Models, Molecular , Molecular Sequence Data , Poxviridae/chemistry , Poxviridae/genetics , Protein Binding , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Deletion/genetics , Static Electricity , Structure-Activity Relationship , Surface Properties , Viral Proteins/genetics , Viral Proteins/immunologyABSTRACT
Porphyromonas gingivalis is thought to be one of the major pathogenic organisms of adult periodontitis. Of the several virulence factors associated with the pathology it causes, evidence is now presented suggesting that outer membrane vesicles, which form from blebbing of the outer membrane, may also contribute to the pathogenesis of this bacterium. To evaluate this possibility, outer membrane vesicles were isolated from cultures of P. gingivalis and tested for their ability to promote inflammation and for their effects on the biosynthesis of E-selectin and ICAM-1 adhesion molecules and MHC class II glycoproteins. The results indicate that these vesicles are capable of inducing acute inflammation characterized by the accumulation of a large number of neutrophils in the connective tissue. This cellular response corresponds to the vesicle-mediated biosynthesis and surface membrane expression of E-selectin and ICAM-1 by vascular endothelial cells. In contrast, IFN-gamma-dependent synthesis of MHC class II molecules was found to be inhibited by vesicles. Inhibition of HLA-DR expression occurred regardless of whether vesicles were added at the same time as, 24 h before, or 24 h after IFN-gamma stimulation of endothelial cells, suggesting that the inhibitory effects occur at both the membrane and intracellular level. These findings, taken together, indicate that P. gingivalis membrane vesicles are capable of inducing and regulating cellular responses involved in inflammation and initiation of acquired immunity. Membrane vesicles are composed of muramyl peptides, periplasmic proteins and outer membrane constituents. The combination of these components probably contribute to the immune regulatory functions reported herein.
Subject(s)
Cell Membrane/immunology , Endothelium, Vascular/immunology , HLA-DR Antigens/biosynthesis , Interferon-gamma/pharmacology , Porphyromonas gingivalis/immunology , Animals , Connective Tissue/immunology , E-Selectin/biosynthesis , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Flow Cytometry , Humans , Inflammation/etiology , Intercellular Adhesion Molecule-1/biosynthesis , Mice , Neutrophils/physiology , Recombinant Proteins , Umbilical CordABSTRACT
Glycosaminoglycans (GAGs) are a group of negatively charged molecules present in many tissues as components of the extracellular matrix, basement and cellular membranes. This work analysed the ability of this group of substances to interact with human interferon gamma and the effect of those interactions on its biologic activity. A variety of GAGs (heparin, heparan sulfate, chondroitin sulfate and hyaluronic acid), and a related sulfated polysaccharide (dextran sulfate), were found to interact with IFN-gamma as determined by inhibition of the binding of [125I]IFN-gamma to COLO-205 cells and binding to wells coated with GAGs. These interactions were inhibited by synthetic peptides mimicking the sequences of the basic amino acid cluster located at the C-terminal end of mouse and human IFN-gamma, or by poly-L-lysine, suggesting that ionic interactions between the positively-charged C-terminus and negatively charged groups in GAGs were involved. IFN-gamma molecules bound to plate-immobilized or endothelial cell surface GAGs retained biological activity, since they could induce major histocompatibility complex (MHC) class II expression on COLO-205 cells, suggesting that cell surface GAGs might be able to present IFN-gamma to its receptors. These results suggest important regulatory roles for GAGs on the activity of IFN-gamma in vivo.
Subject(s)
Glycosaminoglycans/metabolism , Interferon-gamma/metabolism , Animals , Antibody Formation , Binding, Competitive , Cytokines/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Heparin/metabolism , Histocompatibility Antigens Class II/biosynthesis , Humans , Hydrogen-Ion Concentration , Iodine Radioisotopes , Mice , Protein Binding , Solubility , Tumor Cells, CulturedABSTRACT
Human vascular endothelial cells can be induced by IFN-gamma to express class II MHC proteins. Previously, dextran sulfate was shown to selectively inhibit expression of class II MHC by preventing transcription of the gene encoding CIITA, a transactivator protein required for IFN-gamma-inducible expression of class II genes. In this study we characterized the effects of dextran sulfate on the intracellular events occurring prior to CIITA activation. Immunoprecipitation and Western blot analyses indicated that IFN-gamma-induced phosphorylation of Stat1 and Jak2 was blocked by dextran sulfate. In addition, electron micrographs showing the large accumulation of dextran sulfate particles in the cytoplasms of endothelial cells demonstrated that Stat and Jak proteins may directly interact with dextran sulfate. Binding of radiolabeled IFN-gamma to cells indicated that dextran sulfate may also modulate IFN-gamma interactions with the cell surface. Thus, dextran sulfate is capable of interfering with the IFN-gamma-induced expression of class II MHC genes at multiple sites.
Subject(s)
DNA-Binding Proteins/metabolism , Dextran Sulfate/pharmacology , Endothelium, Vascular/metabolism , Interferon-gamma/pharmacology , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins , Trans-Activators/metabolism , Dextran Sulfate/pharmacokinetics , Endothelium, Vascular/cytology , Genes, MHC Class II , Histocompatibility Antigens Class I/analysis , Humans , Janus Kinase 2 , Phosphorylation , STAT1 Transcription Factor , STAT2 Transcription FactorABSTRACT
A major hallmark of Alzheimer's disease (AD) is the presence of extracellular amyloid plaques consisting primarily of amyloid beta peptide (A beta) which is derived from a larger beta-amyloid precursor protein (APP). APP is processed via secretory and endosomal/lysosomal pathways by a group of proteases called secretases. During the processing of APP, the carboxy-terminal tail fragment has been suggested to remain within the cell. To investigate the fate of this fragment, we generated an antibody specific for a nine amino acid residue, the sequence of which was derived from the carboxy-terminal putative cytoplasmic tail of APP. Computer analysis of the entire APP gene, searching for regions of greatest antigenicity, surface probability, hydrophilicity, and presence of beta turns, indicated that the cytoplasmic tail region is an immunodominant region of APP. The peptide coupled to keyhole limpet hemocyanin protein, produced a very high titer antibody (1:1 x 10(6)). To evaluate the specificity of the antibody, immunoprecipitation of in vitro transcribed and translated DNA encoding the carboxy-terminal amino acids of APP in wheat germ extract was carried out. A single immunoprecipitated band of the correct size was seen by SDS-PAGE. The antibody was also able to specifically detect the accumulation of the stable C-terminal tail containing fragments of APP in neurites of the amygdala and hippocampus regions of the human brain tissue from AD subjects, but did not react with age-matched control normal brain tissue. The localization of the C-terminal tail of APP within the brain tissue of AD patients underscores the likely importance of the C-terminus in the pathogenesis of AD.
Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Protein Precursor/analysis , Brain Chemistry , Peptide Fragments/analysis , Amino Acid Sequence , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Humans , Immunohistochemistry , Mass Spectrometry , Molecular Sequence Data , RNA, Messenger/biosynthesis , Transcription, GeneticABSTRACT
Vaccinia virus (VV) and other pathogenic poxviruses encode for a complement control protein. The VV complement control protein or VCP, was one of the first soluble microbial proteins postulated to have an active role in the immunomodulation of the host defense. Since then, 2 other poxviruses, including variola virus and cowpox virus (CPV), were found to have corresponding proteins. Based upon earlier studies which demonstrated the role of the CPV complement control protein in modulating the specific tissue responses in BALB/c and congenic-matched C5-sufficient and C5-deficient mice, the CPV equivalent has been renamed the inflammation modulatory protein (IMP), so as to specifically reflect its function. In this study, the in vivo cellular response of mice injected with CPV or a recombinant virus lacking the IMP sequence (CPV-IMP) was examined using a connective tissue air pouch model. Microscopic examination revealed that CPV-IMP caused a significant mononuclear cell infiltration into the connective tissue and adjacent dermal tissue of the skin. To characterize IMP's ability to regulate the observed cellular infiltration through both complement derived and non-complement derived chemotactic factors, footpad and skin connective tissue of C3 knockout mice and footpad of MIP-1alpha knockout mice received injections of CPV and CPV-IMP. In comparison to the matched control, significantly greater footpad specific swelling response was seen in C3 -/- mice injected with CPV. This indicates an important role for C3 in poxvirus pathogenesis. However, MIP-1 alpha -/- mice injected with CPV-IMP recovered earlier than mice injected with CPV alone. This indicates that the function of IMP in vivo in mice with a complete repertoire of immune components is to limit cellular infiltration by down regulating the complement derived chemotactic analphylotoxins, thereby modulating the inflammatory response contributing to a diminished tissue pathology and preservation of viral habitat.
Subject(s)
Complement Activation/immunology , Down-Regulation/immunology , Viral Proteins/immunology , Animals , Complement Activation/physiology , Complement C3/genetics , Complement C3/immunology , Complement C5/genetics , Complement C5/immunology , Connective Tissue/immunology , Connective Tissue/metabolism , Cowpox virus/genetics , Cowpox virus/immunology , DNA, Recombinant/genetics , DNA, Viral/genetics , Down-Regulation/physiology , Female , Gene Targeting , Immunity, Cellular/immunology , Immunity, Cellular/physiology , Inflammation/immunology , Inflammation/metabolism , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Models, Biological , Viral Proteins/genetics , Viral Proteins/physiologyABSTRACT
It is proposed that the genesis of extracellular membrane vesicles in Gram-negative bacteria is a result of cell wall turnover. Peptidoglycan turnover would cause a turgor on the outer membrane, causing the outer membrane to bulge and finally bleb. Mechanical motion would then shear the blebs into the culture medium.
Subject(s)
Gram-Negative Bacteria/ultrastructure , Porphyromonas gingivalis/ultrastructure , Bacterial Outer Membrane Proteins/analysis , Cell Wall/chemistry , Cell Wall/metabolism , Electrophoresis, Polyacrylamide Gel , Gram-Negative Bacteria/chemistry , Gram-Negative Bacteria/physiology , Humans , Muramic Acids/analysis , Peptides/analysis , Porphyromonas gingivalis/chemistry , Porphyromonas gingivalis/physiology , Proteins/analysisABSTRACT
Microorganisms encode numerous immunomodulators that resemble, in structure and function, molecules captured over the millennia from their hosts [G. J. Kotwal J. Leukoc. Biol. 62, 415-429]. The vaccinia virus complement control protein (VCP) was the first soluble microbial protein to have a postulated role in the immunomodulation and evasion of host defense [G. J. Kotwal and B. Moss Nature 355, 176-179]. Purified bioactive VCP has been shown to bind to C3 and C4, block the complement cascade at multiple sites [G. J. Kotwal et al. Science 250, 827-830; R. Mckenzie, G. J. Kotwal et al. J. Infect. Dis. 166, 1245-1250] and exhibit a greater potency than the human complement 4b binding protein, C4b-BP [G. J. Kotwal, Am. Biotech. Lab. 9, 76]. The importance of this protein to poxviruses was further demonstrated in rabbits and guinea pigs through the use of recombinant virus lacking an intact DNA coding for VCP [Isaacs, G. J. Kotwal, and B. Moss Proc. Natl. Acad. Sci. 89, 628-672]. Studies in mice have shown that the homolog of VCP in cowpox virus (CPV), referred to as the inflammation modulatory protein (IMP) can, in a mouse model, significantly diminish the specific footpad swelling response [C. G. Miller, S. N. Shchelkunov, and G. J. Kotwal Virol. 229, 126-133]. To determine the precise cellular changes at the site of infection, BALB/c mice were subcutaneously injected (in the backs) with CPV or a recombinant virus lacking IMP, CPV-IMP. Differences in histology were observed by staining the adjoining skin tissue sections with hematoxylin & eosin or by removal of the connective tissue and staining with May-Grunwald-Geimsa. All mice that were injected with the CPV-IMP experienced severe tissue destruction and formation of nodular lesions compared with the mice injected with CPV. Microscopic examination indicated significantly greater cellular infiltration and destruction of skeletal muscle cells in the sections of connective tissue and adjoining skin tissue, respectively, of the mice injected with the CPV-IMP [G. J. Kotwal et al. Mol. Cell. Biochem. in press]. Thus IMP preserves the tissue at the site of infection (viral habitat). In this review, we present evidence for molecular mimicry and evolutionary relationship to other homologs of IMP and discuss their relationships with other IMPs such as the poxviral chemokine and cytokine receptor-like proteins.
Subject(s)
Inflammation Mediators/immunology , Inflammation/immunology , Inflammation/virology , Molecular Mimicry , Poxviridae/immunology , Viral Proteins/immunology , Amino Acid Sequence , Animals , Base Sequence , Humans , Mice , Mice, Knockout , Molecular Sequence DataABSTRACT
Major histocompatibility class II molecules (MHC class II), whose biosynthesis and expression by endothelial cells can be induced by gamma-interferon (IFN-gamma), play a major role in antigen recognition and subsequent cell-cell interactions involved in the initiation of immune responses. Adhesion molecules such as E-selectin and intercellular adhesion molecules (ICAM-1), whose biosynthesis and membrane expression by endothelial cells is regulated by proinflammatory cytokines (IL-1 and TNF), are necessary for the attachment and subsequent extravasation of leukocytes into the surrounding tissue. In the present study, the effects of preformed inflammatory mediators (histamine and serotonin) on the induction and expression of MHC class II, E-selectin, and ICAM-1 molecules by human umbilical vein endothelial cells were examined. Serotonin but not histamine was found to significantly inhibit in a dose-response fashion the induction and expression of MHC class II molecules. Inhibition occurred when it was added 24 h before, at the same time (most effective), or 24 h after IFN-gamma stimulation. No enhancement or stimulation of MHC class II biosynthesis could be detected using moderate or low concentration of either histamine or serotonin alone. In contrast to MHC class II molecules, neither serotonin nor histamine blocked the induction and biosynthesis of E-selectin and ICAM-1 molecules as detected by specific H18/7 and RR1/1 monoclonal antibodies, respectively, using flow cytometry. These findings suggest that serotonin but not histamine can assist in regulating the induction and expression of MHC class II molecules. Failure to block biosynthesis of E-selectin and ICAM-1 induced by TNF-alpha and IL-1 beta indicates the inhibitory effect exerted by serotonin was selective in nature.
Subject(s)
Cell Adhesion Molecules/biosynthesis , Endothelium, Vascular/drug effects , Endothelium, Vascular/immunology , Histocompatibility Antigens Class II/biosynthesis , Serotonin/pharmacology , Cells, Cultured , E-Selectin/biosynthesis , Histamine/pharmacology , Humans , Intercellular Adhesion Molecule-1/biosynthesis , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Recombinant Proteins , Signal Transduction , Tumor Necrosis Factor-alpha/pharmacologyABSTRACT
IFN-gamma-activated endothelial cells actively participate in initiating immune responses by interacting with immunocompetent cells via class II MHC proteins. In this study, dextran sulfate, a synthetic heparin analogue, was shown to selectively inhibit IFN-gamma-induced surface expression of HLA-DR molecules by human umbilical cord vascular endothelial cells, but not other cytokine-induced molecules such as ELAM-1 or ICAM-1. Inhibition occurred regardless of whether dextran sulfate was added 24 h before, at the same time as, or 24 h after IFN-gamma stimulation of cells. In addition, both high (500 kDa) and low (5 kDa) molecular mass dextran sulfate molecules were able to block class II expression, whereas treating cells with naturally occurring polysulfated glycosaminoglycans such as heparin, heparan, and chondroitin sulfate did not produce any suppressive effects. Radiolabeling of cells with [35S]methionine followed by radioimmunoprecipitation using anti-HLA-DR alpha mAb demonstrated that biosynthesis of class II proteins was specifically blocked. RT-PCR and Southern blotting were utilized to examine transcription of the HLA-DR alpha gene and demonstrated an absence of HLA-DR alpha mRNA from dextran sulfate-treated and IFN-gamma-induced cells. Dextran sulfate also prevented transcription of the gene encoding CIITA, a transactivator protein required for IFN-gamma-inducible expression of class II genes. Thus, dextran sulfate apparently inhibited this step or an earlier one in the intracellular signaling pathway for IFN-gamma in human endothelial cells, subsequent to IFN-gamma binding to its cell surface receptor.
Subject(s)
Dextran Sulfate/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Gene Expression Regulation/drug effects , Genes, MHC Class II/drug effects , HLA-DR Antigens/drug effects , HLA-DR Antigens/genetics , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/pharmacology , Nuclear Proteins , Base Sequence , Cell Adhesion Molecules/drug effects , Cytokines/drug effects , Cytokines/pharmacology , Dextran Sulfate/metabolism , Humans , Molecular Sequence Data , Trans-Activators/drug effects , Trans-Activators/genetics , Transcription, Genetic/drug effects , Umbilical Cord/cytologyABSTRACT
The role of dietary copper deficiency in platelet-to-endothelial cell adhesion and in platelet-to-platelet aggregation was studied in vitro. Platelets were obtained from male, weanling Sprague-Dawley rats fed purified diets which were either copper-adequate (CuA, 6.3 micrograms copper/g of diet) or copper-deficient (CuD, 0.3 microgram/g of diet) for 4 weeks. The platelet adhesion study was performed by adding CuA or CuD platelets either suspended in homologous plasma or in Tyrode buffer salt solution (TBSS) to cultured rate endothelial cells. After a one hour incubation at 37 degrees C non-adhered platelets were removed and counted in a microcytometer. Platelet aggregation in platelet rich plasma (PRP) samples was induced by adding ADP (2 x 10(-4)M) and measured in a turbidometric aggregometer. The content of von Willebrand factor (vWF) in platelets and in plasma and the content of fibrinogen in platelets was determined. Platelet adhesion to rat endothelial cells was significantly lower for platelets from CuD rats than for platelets from CuA rats. ADP induced platelet aggregation from CuD rats was significantly higher than platelet aggregation from CuA rats. The content of vWF in platelets and in plasma from CuD rats was significantly lower than in platelets and plasma from CuA rats. However, the amount of fibrinogen in platelets from ++CuD rats was about 4-fold higher than that in platelets from CuA rats while the plasma fibrinogen was lower in CuD rats than in CuA rats. These studies illustrate that copper deficiency diminishes platelet adhesion to endothelial cells but increases platelet aggregability. The results suggest that these physiological alterations may be the result of decreased platelet vWF and increased platelet fibrinogen during dietary copper deficiency.
Subject(s)
Copper/deficiency , Diet/adverse effects , Platelet Adhesiveness/physiology , Platelet Aggregation/physiology , Animals , Cells, Cultured , Fibrinogen/analysis , Liver/metabolism , Male , Rats , Rats, Sprague-Dawley , von Willebrand Factor/analysisABSTRACT
Poxviruses are a large, complex group of highly successful pathogens that cause disease in humans and other animals. They encode several proteins postulated to be involved in the evasion of host immunity and therefore serve as excellent models for understanding virus-host interaction during the early stages of viral infection. Vaccinia virus, the best characterized member of the poxviridae family, encodes a 35-kDa major secretory polypeptide termed vaccinia virus complement control protein (VCP), which is structurally related to the family of human and mouse complement control proteins. Members of the family of complement control proteins have been shown to inhibit complement-mediated opsonization of bacteria and induction of inflammatory and phagocytic responses in vitro. Insertional inactivation of the VCP gene results in attenuation of viral virulence in vivo. The role of host complement in the inflammatory response to poxvirus infection has not been systematically investigated. Prior to determining the role of VCP on inflammatory responses in vivo, we decided to investigate the role of host complement in the progression of viral infection. We have compared the effects of injection of cowpox virus, primarily a rodent virus, into footpads of congenic mice strains B10.D2/nSnJ (C5-sufficient) and B10.D2/oSnJ (C5-deficient). The effects of the injection were monitored macroscopically by measuring the specific swelling response immediately following primary injection and subsequently after reinfection and by histological examination of the stained sections of the footpads. Our results indicate that there is a significant variation in the primary response in the two different mouse strains to cowpox virus infection. The specific swelling response observed in measurements from the footpads of the B10.D2/oSnJ mice was significantly greater, persisted for a longer duration, and was accompanied by severe ulceration, edema, induration, and hemorrhaging. Reinjection of the footpads after a 3-month period, during which time the swelling had subsided and the footpad had fully recovered to its original size and appearance, showed no significant differences between the two strains. This strongly suggests that the host complement plays a significant role during the initial response to poxvirus infection.
Subject(s)
Complement C5/deficiency , Cowpox virus/pathogenicity , Cowpox/immunology , Animals , Cowpox/pathology , Female , Foot , Immunity, Cellular , Inflammation/immunology , Male , Mice , Mice, Inbred StrainsABSTRACT
Reperfusion of ischemic tissue is associated with tissue injury greater than that resulting from ischemia alone. C activation has been hypothesized to mediate the so-called ischemia/reperfusion injury through both membrane attack and C5a-dependent recruitment of neutrophils to sites of C3 fixation on the endothelium via C3 receptors. Adherence of neutrophils is preconditional to expression of their deleterious effects, which are central to the pathophysiology of ischemia/reperfusion injury. This study was designed to evaluate the effect of inhibition of C activation on ischemia/reperfusion injury using a soluble and truncated recombinant human CR1 (sCR1) molecule, a "tail-less" form of the membrane C3b/C4b receptor (CD35) that functions as a regulator of C activation. Capillary perfusion and leukocyte adherence to venular endothelium were measured after reperfusion in a mouse cremaster muscle model that allowed microscopic video observation of microcirculatory changes. Infusion i.v. with sCR1 before a 4-h period of ischemia and during a 3-h subsequent period of reperfusion prevented the increase in leukocyte adherence to venular endothelium seen in controls, and enhanced the number of reperfusing capillaries by 55%. Trypan blue staining showed an increase in muscle cell viability from 11 to 50% in mice receiving sCR1 as compared to controls. Tests of blood samples from mice infused with sCR1 demonstrated nearly complete inhibition of the mouse alternative pathway of C activation, but no detectable loss of the mouse classical pathway of C activation. It was concluded that C activation in this model of skeletal muscle injury is likely to be due to the alternative pathway, and that inhibition of C activation during reperfusion inhibits leukocyte adherence to blood vessel walls and protects the capillary microcirculation.
Subject(s)
Complement Inactivator Proteins/pharmacology , Ischemia/immunology , Microcirculation/immunology , Muscles/blood supply , Receptors, Complement 3b/physiology , Reperfusion Injury/immunology , Animals , Binding, Competitive , Complement Activation/drug effects , Disease Models, Animal , Humans , Ischemia/physiopathology , Male , Mice , Microcirculation/drug effects , Rabbits , Recombinant Proteins/pharmacology , Reperfusion Injury/etiology , Reperfusion Injury/physiopathology , Sheep , SolubilityABSTRACT
Mast cell-competent mice, sensitized to lysozyme, were examined for their mast cell and anaphylactic responses to determine whether anaphylactic shock could occur independent of mast cell participation. Tissues (cremaster muscle, subdermal connective tissue and mesentery), taken a short time after intravenous antigenic challenge, showed no evidence of mast cell degranulation above control tissues. Data obtained from a quantitative comparison of the onset and increase in local and systemic anaphylactic and mast cell sensitivities to the antigen provide strong support for the view that mast cells are not the major effector cells for systemic anaphylaxis in mice. The significant increase in blood pressure that occurred immediately after infusion with the antigen also indicates that other cells within the blood stream are involved.
Subject(s)
Anaphylaxis/etiology , Mast Cells/physiology , Animals , Cell Degranulation , Immunoglobulin G/analysis , Male , MiceABSTRACT
Lymphoid and bone marrow cells from normal and horse serum-immunized mice and lymphoid cells from Nippostrongylus brasiliensis-infected mice were cultured on monolayers of embryonic skin fibroblasts to analyze the factors which regulate the differentiation and proliferation of mast cells in vitro. Our results indicate that T cells can regulate the development of mast cells in vitro by either enhancement or suppression. In cultures of horse serum-immune spleen cells, inducer T cells are required for mast cells to develop. However, in cultures of mesenteric lymph node cells from N. brasiliensis-infected mice, inducer T cells are not required for mast cell development. This suggests that the development of mast cells may occur at discrete interleukin-3 (IL-3)-dependent and IL-3-independent stages. Mast cell precursors in the mesenteric lymph nodes of N. brasiliensis-infected mice may have already been acted on by inducer cells in vivo to become mast cell committed. While IL-3 does not appear to be required for mast cell development, these precursors do require the presence of a connective tissue microenvironment such as embryonic skin. The precursors can be inhibited from development by interferon preparations.
Subject(s)
Mast Cells/cytology , Nematode Infections/pathology , Animals , Cell Differentiation/drug effects , Cells, Cultured , Female , Interferon-gamma/pharmacology , Lymph Nodes/cytology , Lymphocyte Depletion , Mesentery , Mice , Mice, Inbred BALB C , Nematode Infections/immunology , Nippostrongylus , T-Lymphocytes, Helper-Inducer/physiologyABSTRACT
To a considerable degree, malaria-induced immunosuppression has been attributed to an inhibition of macrophage accessory cell function. In this study hemozoin, a plasmodium hemoglobin degradation product which readily accumulates in phagocytic cells and tissues during infection, was examined for its influence on immune responses. Hemozoin-laden liver and splenic macrophages from Plasmodium berghei-infected mice, displayed accessory cell dysfunction which was likely due to hemozoin loading by these phagocytic cells. This indicated by the observation that hemozoin obtained from livers and spleens of infected mice as well as from Plasmodium falciparum cultures greatly inhibited splenic plaque-forming cell responses to sheep red blood cells. The results of the present study strongly suggest that the inhibition of macrophage accessory cell activity is due, at least in part, to the uptake and accumulation of hemozoin in their cytoplasms.
Subject(s)
Hemeproteins/pharmacology , Malaria/immunology , Animals , Cell Adhesion , Female , Hemeproteins/biosynthesis , Hemeproteins/isolation & purification , Immune Tolerance , Macrophages/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Plasmodium berghei/metabolism , Plasmodium falciparum/metabolism , Spleen/cytology , Spleen/drug effectsABSTRACT
An increasing number of severe, even fatal cases of strongyloidiasis in patients on immunosuppressive drugs are being reported. During a 26 month period, three severe cases of Strongyloides stercoralis infestation were diagnosed in patients who were on steroid therapy. These cases are of special interest because of the following factors. Firstly, all the patients lived in a nonendemic metropolitan area. Secondly, a single stool specimen from one patient contained several distinct developmental stages of the parasite's life cycle. This finding appears to be unique considering the fact that the patient had not been administered a purgative or anthelminthic. Lastly, a surviving renal transplant patient continues to have persistent strongyloidiasis despite repeated Mintezol (thiabendazole) therapy.
Subject(s)
Immunosuppressive Agents/adverse effects , Strongyloidiasis/etiology , Adult , Humans , Male , Middle Aged , Parasite Egg Count , Strongyloidiasis/pathologyABSTRACT
Mast cell degranulation which occurred following the subcutaneous injection of trichinella larval antigen into trichinella-infected mice was found to be associated with antigen binding by the released granules and with the uptake of granule antigen complexes by phagocytic cells. Similar activity could be demonstrated in vitro, and in addition it was found that living intact mastocytoma and peritoneal mast cells rapidly took up fluorescein-labeled larval antigen and stored it in their cytoplasmic granules as evidenced by perigranular fluorescence. Complex formation between heparin and trichinella antigens as well as other related and unrelated parasitic antigens could readily be demonstrated using in vitro methods. These observations strongly suggest that mast cells play a significant and important supportive role in parasitic infections.